UA99951U - Method of determining the indications for invasive research at nodal formations - Google Patents

Method of determining the indications for invasive research at nodal formations

Info

Publication number
UA99951U
UA99951U UAU201501506U UAU201501506U UA99951U UA 99951 U UA99951 U UA 99951U UA U201501506 U UAU201501506 U UA U201501506U UA U201501506 U UAU201501506 U UA U201501506U UA 99951 U UA99951 U UA 99951U
Authority
UA
Ukraine
Prior art keywords
determining
biopsy
indications
factor
deformation
Prior art date
Application number
UAU201501506U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Микола Васильович Гульчій
Вікторія Олександрівна Сердюк
Сергій Миколайович Цимбалюк
Олександр Борисович Олійник
Original Assignee
Микола Васильович Гульчій
Сергій Миколайович Цимбалюк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Микола Васильович Гульчій, Сергій Миколайович Цимбалюк filed Critical Микола Васильович Гульчій
Priority to UAU201501506U priority Critical patent/UA99951U/en
Publication of UA99951U publication Critical patent/UA99951U/en

Links

Abstract

Method of determining the indications for invasive research at nodal formations involves performing thyroid ultrasound and detection of nodules on ehosymeotykoyu. Additionally, perform sonoelastohrafiyu thyroid capability compared to the deformation of the surrounding parenchyma and formation determining factor digital indicator strain. In terms of factor of 1 to 3 indicate benign tumors, which does not require biopsy studies, the rates of 3 to 4 tumors considered "risk zone" with the obligatory biopsy, if the rate of deformation factor of more than 4 -x - abnormal formation of malignant believe to be removed to operating without a biopsy.
UAU201501506U 2015-02-20 2015-02-20 Method of determining the indications for invasive research at nodal formations UA99951U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201501506U UA99951U (en) 2015-02-20 2015-02-20 Method of determining the indications for invasive research at nodal formations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201501506U UA99951U (en) 2015-02-20 2015-02-20 Method of determining the indications for invasive research at nodal formations

Publications (1)

Publication Number Publication Date
UA99951U true UA99951U (en) 2015-06-25

Family

ID=53676108

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201501506U UA99951U (en) 2015-02-20 2015-02-20 Method of determining the indications for invasive research at nodal formations

Country Status (1)

Country Link
UA (1) UA99951U (en)

Similar Documents

Publication Publication Date Title
TN2013000358A1 (en) Fgfr and ligands thereof as biomarkers for breast cancer in hr positive subjects
EP4242329A3 (en) Use of markers including filamin a in the diagnosis and treatment of prostate cancer
GB201312856D0 (en) Malware Detection
EP4219765A3 (en) Prostate cancer prognosis using biomarkers
MX2018005071A (en) Treatment of small cell lung cancer with a parp inhibitor.
MX2018009304A (en) Diagnostic and prognostic methods for cardiovascular diseases and events.
MX2022002138A (en) Prostate antigen standards and uses thereof.
GB2545361A (en) Protein biomarker panels for detecting colorectal cancer and advanced adenoma
WO2013025952A3 (en) Methods and compositions for the treatment and diagnosis of breast cancer
WO2011139721A8 (en) Cancer biomarkers and methods of use thereof
EP3495502A3 (en) Biomarkers for premature birth
MX352373B (en) Antibodies against kidney associated antigen 1 and antigen binding fragments thereof.
Safari et al. RETRACTED ARTICLE: Upregulation of miR-20a and miR-10a expression levels act as potential biomarkers of aggressive progression and poor prognosis in cervical cancer
WO2017044694A3 (en) Method of determining the prognosis of hepatocellular carcinomas using a multigene signature associated with metastasis
WO2019178606A8 (en) Methods for personalized detection of the recurrence of cancer or metastasis and/or evaluation of treatment response
UA99951U (en) Method of determining the indications for invasive research at nodal formations
WO2016168150A3 (en) Treatment for cancer metastasis
WO2014143794A3 (en) Diagnostic and prognostic marker for prostate cancer
EP3591050A3 (en) Use of rhoa in cancer diagnosis and inhibitor screening
GB2569047A (en) Measuring fluid properties based on fluid surface response to a disturbance
GB2553948A (en) Downhole fluids with a particular impedance
Li et al. Detection and quantification of fatigue cracks in rail steel using acoustic emission technique
Breda et al. Erratum to: Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population
UA106268U (en) A method of predicting clinical course of acute destructive pancreatitis
郑苏苏 Correlation between Ki-67 and early recurrence of hepatocellular carcinoma after radical resection